Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction

By W. Müllges, Dorothea Franke, W. Reents, J. Babin-Ebell, K. Toyka, N. Ko, S. Johnston, W. Young, V. Singh, A. Klatsky and 60 more. Cerebrovascular Diseases, 2003

601 citations recorded by the source corpus.

Subfields: Electrochemistry, Epidemiology, Organic Chemistry

View Paper: https://www.semanticscholar.org/paper/a4b266f23152bb68ff9ae60e459b82b27e6d4d9a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Candelario-Jalil
2. Surojit Paul

Citations in the corpus

• Emerging Neuroprotective Strategies for the Treatment of Ischemic Stroke: An Overview of Clinical and Preclinical Studies (2020, background): “However, several adverse side effects of edaravone have also been reported in stroke clinical trials, of which increased renal toxicity is of major concern, although it seems to be reversible in some patients (Edaravone Acute Infarction Study, 2003; Hishida, 2007, 2009; Shinohara et al., 2009).”